GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

A long-acting Factor VIII replacement therapy for haemophilia A from Sobi and Sanofi has been recommended for use by the NHS ...

The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the ...

As such, the 2nd Peptide Formulation & Delivery Innovation Summit (June 24 - 26, 2025 | Boston, MA) returns as the only ...

GUB014295 is a subcutaneously administered long-acting amylin agonist that also stimulates calcitonin receptors, according to ...

Novel analytical methodologies, real-world data (RWD), innovative trial designs, and new technologies are crucial to optimise ...

The Interministerial Commission for the Pricing of Medicines in Spain has backed access by the Spanish National Health System ...

Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, ...

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...

"Many loss of pulse incidents happen when the person is alone, leaving them with effectively no chance of receiving ...

Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...